Pancreatic cancer symptom trajectories from Danish registry data and free text in electronic health records
Open Access
- 21 November 2023
- journal article
- research article
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 12
Abstract
Pancreatic cancer is one of the deadliest cancer types with poor treatment options. Better detection of early symptoms and relevant disease correlations could improve pancreatic cancer prognosis. In this retrospective study, we used symptom and disease codes (ICD-10) from the Danish National Patient Registry (NPR) encompassing 6.9 million patients from 1994 to 2018,, of whom 23,592 were diagnosed with pancreatic cancer. The Danish cancer registry included 18,523 of these patients. To complement and compare the registry diagnosis codes with deeper clinical data, we used a text mining approach to extract symptoms from free text clinical notes in electronic health records (3078 pancreatic cancer patients and 30,780 controls). We used both data sources to generate and compare symptom disease trajectories to uncover temporal patterns of symptoms prior to pancreatic cancer diagnosis for the same patients. We show that the text mining of the clinical notes was able to complement the registry-based symptoms by capturing more symptoms prior to pancreatic cancer diagnosis. For example, ‘Blood pressure reading without diagnosis’, ‘Abnormalities of heartbeat’, and ‘Intestinal obstruction’ were not found for the registry-based analysis. Chaining symptoms together in trajectories identified two groups of patients with lower median survival (<90 days) following the trajectories ‘Cough→Jaundice→Intestinal obstruction’ and ‘Pain→Jaundice→Abnormal results of function studies’. These results provide a comprehensive comparison of the two types of pancreatic cancer symptom trajectories, which in combination can leverage the full potential of the health data and ultimately provide a fuller picture for detection of early risk factors for pancreatic cancer.Keywords
All Related Versions
Funding Information
- Novo Nordisk Fonden (NNF17OC0027594)
- Novo Nordisk Fonden (NNF14CC0001)
- BrainDrugs (R279-2018-1145)
- ImmunAid (779295)
- ELIXIR-CONVERGE (871075)
- RiskHunt3r (974537)
This publication has 43 references indexed in Scilit:
- Jaundice: an important, poorly recognized risk factor for diminished survival in patients with adenocarcinoma of the head of the pancreasHPB, 2014
- The SPECIES and ORGANISMS Resources for Fast and Accurate Identification of Taxonomic Names in TextPLOS ONE, 2013
- The prognostic role of time to diagnosis and presenting symptoms in patients with pancreatic cancerCancer Epidemiology, 2013
- Mining electronic health records: towards better research applications and clinical careNature Reviews Genetics, 2012
- The Danish National Patient RegisterScandinavian Journal of Public Health, 2011
- The Danish Cancer RegistryScandinavian Journal of Public Health, 2011
- Weight Loss Precedes Cancer-Specific Symptoms in Pancreatic Cancer-Associated Diabetes MellitusPancreas, 2011
- Pancreatic CancerNew England Journal of Medicine, 2010
- Excess premature (3-month) mortality in advanced pancreatic cancer could be related to fatal vascular thromboembolic events. A hypothesis based on a systematic review of phase III chemotherapy studies in advanced pancreatic cancerActa Oncologica, 2008
- Trousseau’s syndrome – what is the evidence?Thrombosis and Haemostasis, 2006